Mallinckrodt Pharmaceuticals Blog
Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

National Pharmaceutical Council

Fostering an Environment that Supports Medical Innovation

  • by Gena Holthaus
  • Posted on November 28, 2018
  • Advocacy

Guest post by Steve Romano, MD, Executive Vice President and Chief Scientific Officer for Mallinckrodt This month marks my first in the appointed role of chair of the Board-level Research Committee for the National Pharmaceutical […]

Read More
  • Mallinckrodt_EmployeeCampaign_BlogPosts_600x_325_DanaSaporito

    Meet Dana Saporito, National Director, Clinical Specialist Team

    February 19, 2019
  • Mallinckrodt_EmployeeCampaign_BlogPosts_600x_325Catherine

    Meet Catherine Jackson, Director of Advocacy Relations

    February 11, 2019
  • Animal STL control

    Animals Tug on the Heartstrings of Mallinckrodt Volunteer Teams

    February 4, 2019
  • Mallinkcrodt_EmployeeCampaign_Blog_600x_325_MonicaMinguzzi FINAL

    Meet Monica Minguzzi, Senior Director, Global Clinical Specialist Team

    February 4, 2019
  • Mallinkcrodt_EmployeeCampaign_BlogPosts_600x_325_JohnMulroy

    Meet John Mulroy, Director, GPO/IDN Northeast

    January 28, 2019

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

Meet Dana Saporito, National Director, Clinical Specialist Team

Mallinckrodt_EmployeeCampaign_BlogPosts_600x_325_DanaSaporito

Meet Catherine Jackson, Director of Advocacy Relations

Mallinckrodt_EmployeeCampaign_BlogPosts_600x_325Catherine

Animals Tug on the Heartstrings of Mallinckrodt Volunteer Teams

Animal STL control

Meet Monica Minguzzi, Senior Director, Global Clinical Specialist Team

Mallinkcrodt_EmployeeCampaign_Blog_600x_325_MonicaMinguzzi FINAL

Meet John Mulroy, Director, GPO/IDN Northeast

Mallinkcrodt_EmployeeCampaign_BlogPosts_600x_325_JohnMulroy

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
YouTube
LinkedIn
SHARE

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.